Go Deep
Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 15,298 | -62.9 | 5.12 | 1.05 | 29,143.32 |
| Oct 2026 | 15,292 | -62.9 | 5.12 | 1.05 | 28,900.24 |
| Oct 2026 | 15,884 | -62.3 | 5.07 | 1.05 | 28,476.78 |
| Oct 2026 | 15,814 | -62.9 | 5.12 | 1.05 | 28,674.14 |
| Oct 2026 | 15,714 | -63.1 | 5.20 | 1.05 | 29,080.87 |
| Oct 2026 | 15,858 | -62.5 | 5.09 | 1.05 | 28,428.69 |
| Oct 2026 | 15,861 | -62.5 | 5.09 | 1.05 | 28,446.81 |
| Oct 2026 | 15,495 | -65.7 | 5.35 | 1.05 | 29,909.83 |
| Oct 2026 | 15,030 | -71.8 | 5.85 | 1.05 | 32,618.55 |
| Oct 2026 | 15,181 | -70.8 | 5.76 | 1.05 | 32,060.79 |
Charles River Laboratories International, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,004,078,000.0 | 995,830,000.0 | 994,227,000.0 | 1,004,852,000.0 |
| Net Profit | -1,482,000.0 | -14,843,000.0 | -276,555,000.0 | 54,422,000.0 |
| EPS | -0.0 | -0.3 | -5.6 | 1.1 |
Charles River Laboratories International, Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 4,015,382,000.0 | 4,049,989,000.0 | 4,129,409,000.0 | 3,976,060,000.0 |
| Net Profit | -144,338,000.0 | 10,297,000.0 | 474,624,000.0 | 486,226,000.0 |
| EPS | -2.9 | 0.2 | 9.3 | 9.6 |
Charles River Laboratories International, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 7,135,422,000.0 | 7,528,345,000.0 | 8,195,001,000.0 | 7,602,770,000.0 | — |
| Total Liabilities | 3,924,228,000.0 | 4,020,267,000.0 | 4,536,003,000.0 | 4,579,265,000.0 | — |
| Total Equity | 3,164,630,000.0 | 3,461,503,000.0 | 3,596,882,000.0 | 2,976,293,000.0 | — |
Owes vs Owns
Charles River Laboratories International, Inc. owed $0.62 for every $1 it owned in Jun 2026, up from $0.60 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.62× | 0.55× | 0.53× | 0.55× | 0.60× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Charles River Laboratories International, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 3.0%Receivables 9.9%Inventory 4.2%Fixed assets (tangible) 28.3%Intangible assets 43.5%Long-term investments 2.9%Other assets 8.2%
How it's funded — Dec 2025
Long-term debt 29.6%Payables 2.1%Other liabilities 23.3%Shareholders' equity 45.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 213.8 | 194.6 | 276.8 | 233.9 |
| Receivables | 708.9 | 720.9 | 780.4 | 752.4 |
| Inventory | 299.1 | 278.5 | 380.3 | 255.8 |
| Fixed assets (tangible) | 2,016.6 | 2,016.5 | 2,033.8 | 1,857.4 |
| Intangible assets | 3,104.2 | 3,570.0 | 3,959.1 | 3,805.2 |
| Long-term investments | 207.0 | 218.3 | 243.8 | 311.6 |
| Other assets | 585.8 | 529.4 | 520.9 | 386.5 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 2,111.7 | 2,214.5 | 2,647.1 | 2,707.5 |
| Payables | 148.8 | 140.3 | 168.9 | 205.9 |
| Other liabilities | 1,663.7 | 1,665.4 | 1,719.9 | 1,665.8 |
| Shareholders' equity | 3,211.2 | 3,508.1 | 3,659.0 | 3,023.5 |
| Net tangible assets | 60.4 | -108.5 | -362.2 | -828.9 |
Charles River Laboratories International, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 737,646,000.0 | 734,577,000.0 | 683,898,000.0 | 619,640,000.0 | — |
| Investing Activities | -209,321,000.0 | -245,086,000.0 | -563,155,000.0 | -607,922,000.0 | — |
| Financing Activities | -536,726,000.0 | -550,927,000.0 | -85,521,000.0 | -42,397,000.0 | — |